Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Change in Accured Expenses: 2022-2025

Historic Change in Accured Expenses for Praxis Precision Medicines (PRAX) over the last 4 years, with Sep 2025 value amounting to $1.6 million.

  • Praxis Precision Medicines' Change in Accured Expenses fell 70.84% to $1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.9 million, marking a year-over-year decrease of 41.79%. This contributed to the annual value of $16.1 million for FY2024, which is 289.60% up from last year.
  • As of Q3 2025, Praxis Precision Medicines' Change in Accured Expenses stood at $1.6 million, which was down 54.58% from $3.5 million recorded in Q2 2025.
  • In the past 5 years, Praxis Precision Medicines' Change in Accured Expenses registered a high of $8.1 million during Q4 2024, and its lowest value of -$8.3 million during Q1 2025.
  • Its 3-year average for Change in Accured Expenses is $398,636, with a median of $1.6 million in 2025.
  • Per our database at Business Quant, Praxis Precision Medicines' Change in Accured Expenses spiked by 2,067.11% in 2024 and then crashed by 1,261.84% in 2025.
  • Quarterly analysis of 4 years shows Praxis Precision Medicines' Change in Accured Expenses stood at -$2.0 million in 2022, then spiked by 118.39% to $374,000 in 2023, then spiked by 2,067.11% to $8.1 million in 2024, then crashed by 70.84% to $1.6 million in 2025.
  • Its Change in Accured Expenses was $1.6 million in Q3 2025, compared to $3.5 million in Q2 2025 and -$8.3 million in Q1 2025.